For Investors

Linshom is an early stage, privately held start-up company with a mission to provide continuous respiratory monitoring for patients and health care providers to reduce morbidity & mortality associated with respiratory depression and compromise.

Subsequent to recent FDA clearance (Jan, 2020),  Linshom  is currently raising a series A round of funding that the company will use to  refine the existing sensor and integrate into a multi-parameter monitor.  In parallel Linshom will continue developing the evidence needed for rapid  clinical adoption and commercialization.

Contact for Investors

Richard Hughen - CEO